Opioid Abuse Statistics & Trends in the US: 2019 Data

The Opioid Crisis by the Numbers (2019 CDC Data)

2019 marked a pivotal year: synthetic opioids (fentanyl) overtook prescription opioids as the leading driver of overdose deaths.

Mortality

  • 70,630 total drug overdose deaths.
  • 49,860 involved opioids (70.6%).
  • 36,509 involved synthetic opioids (fentanyl, analogs) — 73% of opioid deaths.
  • 14,019 involved heroin.
  • 14,139 involved prescription opioids (many co-involved with synthetics).

Demographics

  • Age: Highest death rates 25–54; sharp rise in 15–24 and 65+.
  • Sex: Men 2.5x women's rate; but women's increase steeper 1999–2019.
  • Race/Ethnicity: Non-Hispanic White highest crude rate; but Black and Native American rates rising fastest. Age-adjusted: Native American > White > Black > Hispanic > Asian.
  • Geography: Highest age-adjusted rates: WV (52.8/100k), DE, MD, PA, OH. Rural > urban in many states.

Risk Factors

  • Mental illness (depression, anxiety, PTSD)
  • Chronic pain (initial Rx exposure)
  • Prior substance use disorder
  • Unemployment, incarceration history, housing instability
  • High-dose/long-acting opioid prescriptions (>90 MME/day)

Health & Economic Burden

  • Infectious complications: HIV, HCV, endocarditis, osteomyelitis.
  • Neonatal abstinence syndrome (NAS): 1 baby/15 min.
  • $1.02 trillion economic cost (2017 estimate: healthcare, lost productivity, criminal justice, fatality valuation).

Drivers of the Epidemic

  1. Prescription opioid overprescribing (1990s–2010s).
  2. Transition to heroin (cheaper, available).
  3. Illicit fentanyl contamination (heroin, cocaine, counterfeit pills).
  4. Treatment gap: <20% with OUD receive MOUD (methadone, buprenorphine, naltrexone).
  5. Stigma, criminalization, workforce shortages.

Evidence-Based Responses

  • PDMPs + prescribing guidelines.
  • Expand MOUD access (office-based buprenorphine, methadone clinics).
  • Harm reduction: naloxone distribution, syringe services, fentanyl test strips.
  • Contingency management, recovery housing, peer support.
  • Address social determinants: housing, employment, trauma-informed care.

Note

2020–2023 data show further escalation (>100k deaths/year). This 2019 snapshot illustrates the fentanyl inflection point.

Substance Abuse - Related Articles